RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
World Market for Prescription Generic Drugs, 6th Edition
Apr 2008 - 250 pages - $3,995
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
XenoPort Inc: Premium Company Profile
Dec 2007 - 47 pages - $495
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
Premium Company Profile: Neurocrine Biosciences Inc
Nov 2007 - 53 pages - $495
Cypress Bioscience Inc: Premium Company Profile
Feb 2008 - 44 pages - $495
Arena Pharmaceuticals Inc: Premium Company Profile
Dec 2007 - 49 pages - $495
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Product development del
Therapeutic target
Central Nervous System del
Year
2002 del

Browse By

Therapeutic target
Age-related disorders (other)
Amyotrophic lateral sclerosis
CNS (other)
Neurodegenerative disorders
Neurological
Pain
Psychiatric
Subarachnoid hemorrhage
Traumatic brain injury

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us